Waldencast WALD 深 滬
等待開盤 09-24 09:30:00 美东时间
1.02
-0.050
-4.67%
華盛通- 最 高1.13
- 今 開1.05
- 成交量 19.39万股
- 最 低 0.983
- 昨 收 1.07
- 總市值 1.31亿
- 52周最高 3.22
- 市盈率 靜 --
- 換手率 0.15%
- 52周最低 0.72
- 委 比 -78.76%
- 總股本 1.28亿
- 歷史最高 12.10
- 量 比 0.47
- 振 幅 13.74%
- 歷史最低 0.72
- 每 手 1
- 風險率 0.38%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Waldencast to delist from Nasdaq, plans OTC trading under ‘MLKM’
Waldencast (WALD) said it plans to voluntarily delist its Class A shares and warrants from Nasdaq following the divestiture of Obagi Medical. The company expects October 2 to be the last Nasdaq tradin...
09-14 19:42
Waldencast To Voluntarily Delist Its Shares From The Nasdaq
Board to recommend that shareholders approve renaming the Company Milk Makeup plc The Company’s Board of Directors has approved the voluntary delisting of the Company’s Class A Ordinary Shares and Warrants from Nasdaq and the deregistration of those securities under the Exchange Act. Company expects...
09-14 18:56
Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act
Waldencast plc has decided to voluntarily delist its Class A Ordinary Shares and Warrants from Nasdaq and deregister them under the Exchange Act. The company expects to file Form 25 on September 24, 2026, with delisting effective on October 4, 2026, and the last trading day on October 2, 2026. Shareholders will be asked to approve renaming the company to Milk Makeup plc at an Extraordinary General Meeting. After退市, the company plans to seek over-...
09-14 10:55
Waldencast Receives FDA Approval For Obagi Saypha ChIQ Injectable Hyaluronic ACID Gel
Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration ("FDA") has approved Obagi® saypha® ChIQ™ injectable hyaluronic acid ("HA") gel, the latest addition to the Obagi® injectable po...
06-15 21:03
美股大行评级 | 潜在涨幅43%，慧与获11家大行集体上调目标价；最高300美元，Credo获9家大行集体上调目标价
今日重点评级关注：Ascendiant Capital：维持Genasys"买入"评级，目标价从5.5美元升至6美元；Citizens：维持Abivax"跑赢大市"评级，目标价从131美元升至187美元
06-03 11:17
Canaccord Genuity Maintains Buy on Waldencast, Raises Price Target to $3
Canaccord Genuity analyst Susan Anderson maintains Waldencast (NASDAQ:WALD) with a Buy and raises the price target from $2 to $3.
06-02 23:10
美股牛股 | FLNC暴涨超43%，联手英伟达、西门子推出新一代AI工厂设计；全美第六大房企TMHC涨超22%
FLNC暴涨超43%，联手英伟达、西门子推出新一代AI工厂设计；TMHC涨超22%，获伯克希尔68亿美元收购；AMC院线大涨超22%，与Telemundo合作直播世界杯>>
06-02 18:44
12 Consumer Staples Stocks Moving In Monday's Pre-Market Session
Gainers Healthy Choice Wellness (AMEX:HCWC) shares moved upwards by 37.1% to $...
06-01 20:06
Waldencast Sells Obagi Medical To Bridgepoint For Up To $460M
Waldencast plc (NASDAQ:WALD) ("Waldencast" or "the Company") today announced that it has entered into a definitive agreement to sell its Obagi Medical dermatological skincare and aesthetics business ("Obagi Medical") to
06-01 19:02
Obagi Medical Announces New Skincare And Filler Data At Nashville SCALE Meeting
Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ:WALD), today announced new data shared at the Music City SCALE meeting taking place May 13-17
05-15 20:16
